Project Details
Projekt Print View

Neuromuscular endplate pathology in autosomal dominant and recessive desminopathies

Subject Area Molecular and Cellular Neurology and Neuropathology
Pathology
Term from 2018 to 2024
Project identifier Deutsche Forschungsgemeinschaft (DFG) - Project number 413238049
 
Final Report Year 2024

Final Report Abstract

Mutations in the human desmin gene cause a clinically broad spectrum of rare skeletal and cardiac muscle diseases. The vast majority of desminopathies follows an autosomal dominant pattern of inheritance. The very rare autosomal recessive cases can be further subdivided into a group with preserved desmin and a group with abolished desmin expression. There are currently no treatment options available for this clinically progressive and often fatal disease entity. Previous studies have shown that desmin is enriched in the area of the neuromuscular endplates and that patients with a lack of desmin can develop a myasthenic syndrome in addition to myopathy and cardiomyopathy. The aim of the funded project was to study neuromuscular endplate pathology in desminopathies in more detail. Since human tissue was not available due to the rarity of the disease, we analysed skeletal muscle tissue from desmin knock-out and hetero- and homozygous R349P desmin knock-in mice. Our morphological studies showed that the neuromuscular endplates in the soleus muscle of desmin knock-out mice were enlarged and fragmented and that these changes were associated with increased transcript levels of the acetylcholine receptor genes, especially the gamma-subunit. These results are very similar to previously published data in homozygous R349P desmin knock-in mice. Electrophysiological studies in desmin knock-out mice further showed a pathological reduction of nerve-dependent endplate potentials and an increased rise time of nerveindependent miniature endplate potentials. Together with the published cases of patients with recessive desminopathies and myasthenic syndromes, our work in desmin knock-out and homozygous R349P desmin knock-in mice demonstrates that both the absence and the isolated expression of mutant desmin leads to pathological alterations of the structural and functional integrity of neuromuscular endplates. As a clinical consequence, all patients with recessive desminopathies should specifically be examined for the presence of a myasthenic syndrome. Since salbutamol and physiostigmine treatment resulted in a significant improvement of myasthenic symptoms in some of the published patients with recessive desminopathies, this targeted screening is of great therapeutic relevance.

Publications

 
 

Additional Information

Textvergrößerung und Kontrastanpassung